Clinical Trial Update: A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's Disease [Phase 2]

View source ↗

Summary

A phase 2 clinical trial is testing Dapansutrile, an anti-inflammatory medication, in people with Parkinson disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Dapansutrile (dapansutrile)

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Parkinson Disease | Phase 2 | Status: RECRUITING